303 results
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023 (updated)
CHMP, Last updated: 26/05/2023 -
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022 -
List item
News: EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age
CHMP, Last updated: 19/10/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 19/09/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
CHMP, Last updated: 12/11/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
News: EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
Last updated: 29/01/2021 -
List item
News: Extra dose from vials of Comirnaty COVID-19 vaccine
Last updated: 20/01/2021 -
List item
News: EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
Last updated: 06/01/2021 -
List item
News: EMA recommends first COVID-19 vaccine for authorisation in the EU
CHMP, Last updated: 22/12/2020 -
List item
News: EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support
CHMP, Last updated: 02/09/2020 -
List item
Press release: EMA to support development of vaccines and treatments for novel coronavirus disease (COVID-19)
Last updated: 04/02/2020 -
List item
News: Addressing the potential impact of novel coronavirus disease (COVID-19) on medicines supply in the EU
Last updated: 10/03/2020 -
List item
News: COVID-19: EMA meetings with delegates and experts will be held virtually until end April 2020
Last updated: 11/03/2020 -
List item
News: COVID-19: developers of medicines or vaccines to benefit from free scientific advice
Last updated: 13/03/2020 -
List item
News: First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development
Last updated: 18/03/2020 -
List item
Press release: Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments
Last updated: 19/03/2020 -
List item
Press release: Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
Last updated: 20/03/2020 -
List item
Press release: COVID-19: Beware of falsified medicines from unregistered websites
Last updated: 24/03/2020 -
List item
Press release: Global regulators map out data requirements for phase 1 COVID-19 vaccine trials
Last updated: 24/03/2020 -
List item
Press release: EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic
Last updated: 27/03/2020 -
List item
Press release: Update on treatments and vaccines against COVID-19 under development
Last updated: 31/03/2020